53.21
BATS BZX Real-Time Price
As of 3:32pm ET
 +1.23 / +2.37%
Today’s Change
50.67
Today|||52-Week Range
168.92
-35.79%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.7B

Company Description

TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.

Contact Information

TESARO, Inc.
1000 Winter Street
Waltham Massachusetts 02451
P:(339) 970-0900
Investor Relations:
(781) 325-1116

Employees

Shareholders

Mutual fund holders63.22%
Individual stakeholders30.32%
Other institutional28.03%

Top Executives

Lonnie MoulderChief Executive Officer & Director
Mary Lynne HedleyPresident, Chief Operating Officer & Director
Timothy R. PearsonChief Financial & Accounting Officer, Executive VP
Jeffrey H. HankeChief Scientific Officer, Executive VP-R&D
Martin H. HuberChief Medical Officer & Senior Vice President